Therapeutic agents that are able to prevent or attenuate inflammation and ischemia-induced
injury of neural and retinal cells could be used for the treatment of neural and retinal …

Retinal inflammation underlies multiple prevalent retinal diseases. While microglia are one
of the most studied cell types regarding retinal inflammation, growing evidence shows that …

Research has shown that the therapeutic effect of mesenchymal stem cells (MSCs) is
partially due to its secreted factors as opposed to the implantation of the cells into the treated …

In recent years, mesenchymal stem cells (MSC) have been considered the most effective
source for regenerative medicine, especially due to released soluble paracrine bioactive …

The promising field of regenerative medicine is thrilling as it can repair and restore organs
for various debilitating diseases. Mesenchymal stem cells are one of the main components …

Introduction: Retinal homeostasis is essential to avoid retinal pigment epithelium (RPE)
damage resulting in photoreceptor death and blindness. Mesenchymal stem cells-based cell …

Our previous studies have shown the benefit of intravitreal injection of a mesenchymal stem
cell (MSC)-derived secretome to treat visual deficits in a mild traumatic brain injury (mTBI) …

Background: Traumatic brain injury (TBI) is one of the leading causes of morbidity and
mortality today, which will surpass many infectious diseases in the coming years/decades …

Purpose: We compared intravitreal injection of human adipose stem cell concentrated
conditioned media (ASC-CCM) to injection of live ASCs for their long-term safety and …

Cataracts can reduce the quality of vision in visually impaired patients who already have a
visual impairment. The most common causes of low vision include age‐related macular …